Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 18, 2005 | February 23, 2005 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 18, 2005 · Filed February 23, 2005
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.34 · Expires 2015-02-17 | Direct | 91,600 |
Reported balance
After 2005-02-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2005-02-18 · Grant · Acquired 91,600 · Balance 91,600 F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 2/18/06, 30,533 on 2/18/07 and 30,533 on 2/18/08. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 2/18/06, 30,533 on 2/18/07 and 30,533 on 2/18/08.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 91,600 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008019 · a4.xml · derivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,600 Underlying: common shares · 91,600 shares Expires 2015-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 2/18/06, 30,533 on 2/18/07 and 30,533 on 2/18/08. Read SEC document |
| October 28, 2004 Filed Oct 29, 2004 20:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,898 | $0.00 Strike: $42.43 | $0.00 |
DisclosureSEC source: 0001104659-04-032669 · a4.xml · derivative · entry 5 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,898 Underlying: common shares · 7,898 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 28, 2004 Filed Oct 29, 2004 20:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 9,092 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-032669 · a4.xml · derivative · entry 4 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,672 Underlying: common shares · 9,092 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 28, 2004 Filed Oct 29, 2004 20:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,898 | $42.43 | $335,112.14 |
DisclosureSEC source: 0001104659-04-032669 · a4.xml · nonDerivative · entry 2 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,902 Read SEC document |
| October 28, 2004 Filed Oct 29, 2004 20:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 9,092 | $33.23 | $302,139.89 |
DisclosureSEC source: 0001104659-04-032669 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,639 | $0.00 Strike: $41.40 | $0.00 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · derivative · entry 8 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,639 Underlying: common shares · 21,639 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,413 | $0.00 Strike: $41.40 | $0.00 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · derivative · entry 7 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,413 Underlying: common shares · 2,413 shares Expires 2007-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 25,126 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · derivative · entry 6 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 25,126 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,643 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · derivative · entry 5 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,643 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 24,052 | $41.40 | $995,752.80 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 3 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,708 Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 25,126 | $32.61 | $819,386.50 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 2 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,643 | $27.43 | $99,937.69 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2004 Filed Apr 20, 2004 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 16,685 | $0.00 Strike: $43.97 | $0.00 |
DisclosureSEC source: 0001104659-04-010603 · a4.xml · derivative · entry 6 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,685 Underlying: common shares · 16,685 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| April 16, 2004 Filed Apr 20, 2004 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,386 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-04-010603 · a4.xml · derivative · entry 5 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,614 Underlying: common shares · 6,386 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| April 16, 2004 Filed Apr 20, 2004 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 12,741 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-04-010603 · a4.xml · derivative · entry 4 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: common shares · 12,741 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| April 16, 2004 Filed Apr 20, 2004 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 16,685 | $43.97 | $733,639.45 |
DisclosureSEC source: 0001104659-04-010603 · a4.xml · nonDerivative · entry 2 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,991 Read SEC document |
| April 16, 2004 Filed Apr 20, 2004 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 19,127 | $34.70 | $663,706.90 |
DisclosureSEC source: 0001104659-04-010603 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 55,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005606 · a4.xml · derivative · entry 3 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: common shares · 55,000 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 8,000 | $43.66 | $349,280.00 |
DisclosureSEC source: 0001104659-04-005606 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,549 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 12, 2004 Filed Feb 13, 2004 21:50 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,949 | $44.07 | $350,312.43 |
DisclosureSEC source: 0001104659-04-004340 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,549 Read SEC document |
| February 12, 2004 Filed Feb 17, 2004 16:47 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,949 | $44.07 | $350,312.43 |
DisclosureSEC source: 0001104659-04-004635 · a4a.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,549 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 14,455 | $0.00 Strike: $43.57 | $0.00 |
DisclosureSEC source: 0001104659-03-020782 · a4.xml · derivative · entry 5 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,455 Underlying: common shares · 14,455 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 16,487 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-03-020782 · a4.xml · derivative · entry 4 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,741 Underlying: common shares · 16,487 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingcommon shares without par value | 14,455 | $43.57 | $629,804.35 |
DisclosureSEC source: 0001104659-03-020782 · a4.xml · nonDerivative · entry 2 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,498 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversioncommon shares without par value | 16,487 | $34.70 | $572,098.90 |
DisclosureSEC source: 0001104659-03-020782 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.